换一批Tetrahydroquinoline/4,5-Dihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2).
第一作者：
Luis C,Vesga
第一单位：
Faculty of Health Sciences, University of Eastern Finland, Kuopio, 70211, Finland.;Escuela de Química, Universidad Industrial de Santander, A. A. 678, Bucaramanga, Colombia.;Grupo de Investigación en Compuestos Orgánicos de Interés Medicinal CODEIM, Universidad Industrial de Santander, A. A. 678, Piedecuesta, Colombia.
作者：
医学主题词
抗肿瘤药(Antineoplastic Agents);乳腺肿瘤(Breast Neoplasms);剂量效应关系, 药物(Dose-Response Relationship, Drug);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);人类(Humans);异恶唑类(Isoxazoles);模型, 分子(Models, Molecular);分子结构(Molecular Structure);肿瘤蛋白质类(Neoplasm Proteins);喹啉类(Quinolines);构效关系(Structure-Activity Relationship)
DOI
10.1002/cmdc.202100188
PMID
33844464
发布时间
2023-09-21
基金项目
::CSC - IT Center for Science, Finland::
400953/2016-1/Finnish National Agency for Education
006 - 09/2016/Fundação Araucária
110265842934/Vicerrectoría de investigación y Extensión of Universidad Industrial de Santander, Colombia
001/Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil
::Intramural Research Program of the National Institutes of Health::
CA/NCI NIH HHS/United States
RC/CCR NIH HHS/United States
CA/NCI NIH HHS/United States
RC/CCR NIH HHS/United States
- 浏览2
ChemMedChem
2686-2694页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
